Submission of Late Breakers is possible untill Friday Nov. 16.
Please send your Late Breaker abstract as Word doc to email@example.com
Please read the Abstract submission guidelines carefully.
Authors can submit their abstracts electronically using the button on the right once abstract submission has opened. You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract.
IMPORTANT: the free registration is offered to the presenting author of the abstract only.
The applicant should:
- be 30 years of age or younger; or,
- be a Master/PhD student; or,
- have obtained a MD / PhD degree in the last five years
An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least 2 weeks prior to the start of the workshop.
Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.
Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.
Topics for abstract submission
Selection of the most appropriate topic is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.
Abstracts will be accepted either as oral presentations or posters;
Priority will be given to abstracts addressing research in the following areas:
- HIV prevention in women
- Aging and the HIV infected woman
- HCV coinfection
- Injection drug use and women with HIV
- Transmission and progression in HIV infected women, role of contraception
Abstracts can also be submitted under the following categories
- Designing and implementing treatment programs for HIV infected women
- Cervical cancer : HPV screening, treatment, vaccines
- The research agenda and women: what are we doing, what more can/should be done
- The impact of HIV drug resistance on optimal management of women
- Epidemiology of HIV in women and girls
- ARV therapy for women,- efficacy, toxicity, pharmacokinetics
- Contraception, pregnancy, and MTCT
- Social aspects, mental health
Abstract Submission Guidelines
Abstract submission is possible until 1 November.
Abstracts should contain the following four components:
- Background: a concise statement of the issue under investigation or a hypothesis; - Materials & Methods: the experimental methods used (including the statistical analyses employed);
- Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.